Campbell & Co Investment Adviser’s Dynavax Technologies DVAX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-60,400	Closed	-$600K	–	1194
2025 Q3	$600K	Buy	60,400 +20,631	+52%	+$215K	0.05%	640
2025 Q2	$395K	Sell	39,769 -24,624	-38%	-$259K	0.02%	868
2025 Q1	$835K	Buy	+64,393	New	+$852K	0.06%	497
2024 Q1	–	Sell	-39,607	Closed	-$554K	–	1165
2023 Q4	$554K	Buy	+39,607	New	+$550K	0.05%	659
2022 Q2	–	Sell	-18,200	Closed	-$197K	–	731
2022 Q1	$197K	Buy	+18,200	New	+$221K	0.05%	629
2021 Q3	–	Sell	-12,100	Closed	-$119K	–	629
2021 Q2	$119K	Buy	+12,100	New	+$110K	0.05%	490
2020 Q4	–	Sell	-34,300	Closed	-$148K	–	447
2020 Q3	$148K	Buy	+34,300	New	+$245K	0.11%	335

Other funds holding DVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Campbell & Co Investment Adviser's DVAX Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 60,400 shares — an estimated $600K sold.

Campbell & Co Investment Adviser first reported a position in DVAX in Q3 2020 and held it in 7 quarters. The position peaked at $835K in Q1 2025. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

Campbell & Co Investment Adviser reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 60,400 Dynavax Technologies shares in Q4 2025, an estimated $600K.
Campbell & Co Investment Adviser first reported a position in Dynavax Technologies in Q3 2020 and held it in 7 quarters.
Campbell & Co Investment Adviser's Dynavax Technologies position peaked at $835K in Q1 2025.
266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.